Evidence map›Paper›PMID 36203703›Full record

ArticleFrontiers in public health2022

Prevalence of potentially inappropriate medications and association with comorbidities in older adults with diabetes in an outpatient visitation setting.

Lvliang Lu, Keqin Yao, Jiaqi Chen, Yujie Yang, Kai Wang, Jing Zheng, Pi Guo, Yunpeng Cai, Qingying Zhang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Lvliang LuDepartment of Preventive Medicine, Shantou University Medical College, Shantou, China.
Keqin YaoShenzhen Health Development Research and Data Management Center, Shenzhen, China.
Jiaqi ChenDepartment of Preventive Medicine, Shantou University Medical College, Shantou, China.
Yujie YangShenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
Kai WangDepartment of Preventive Medicine, Shantou University Medical College, Shantou, China.
Jing ZhengShenzhen Health Development Research and Data Management Center, Shenzhen, China.
Pi GuoDepartment of Preventive Medicine, Shantou University Medical College, Shantou, China.
Yunpeng CaiShenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
Qingying ZhangDepartment of Preventive Medicine, Shantou University Medical College, Shantou, China.
Shantou University · CNShantou University Medical College · CNShenzhen Institutes of Advanced Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aims: Potentially inappropriate medications had been found associated with adverse drug events such as falls, emergency department admissions and hospital readmissions. There is lack of information about the prevalence of potentially inappropriate medications and associated chronic conditions in older patients with diabetes in China. This study aimed to assess the prevalence of potentially inappropriate medications in older adults with diabetes in an outpatient visitation setting and the association with polypharmacy due to comorbidities. Materials and methods: This was a 3-year repeated cross-sectional study which conducted in outpatient setting of 52 hospitals in Shenzhen, China, using 2019 Beers criteria. The prevalence of potentially inappropriate medications, polypharmacy and comorbidities in older adults with diabetes in an outpatient setting was expressed as percentages. Logistic models were used to investigate the association between potentially inappropriate medication exposure and age, sex, polypharmacy and comorbidities. Results: Among the 28,484 older adults with diabetes in 2015, 31,757 in 2016 and 24,675 in 2017, the prevalence of potentially inappropriate medications was 43.2%, 44.88% and 42.40%, respectively. The top five potentially inappropriate medications were diuretics (20.56%), benzodiazepines (13.85%), androgens (13.18%), non-steroidal anti-inflammatory drugs (12.94%) and sulfonylureas (6.23%). After adjustment for age and polypharmacy, the probability of potentially inappropriate medication exposure was associated with chronic gastrointestinal diseases, followed by osteoarthritis and rheumatoid arthritis, chronic pulmonary disease, chronic kidney disease, tumor, dementia, chronic liver disease, hypertension, cardiovascular disease, cerebrovascular disease and hyperlipemia. Conclusion: Potentially inappropriate medications were common in older patients with diabetes in an outpatient visitation setting. Higher probability of potentially inappropriate medication exposure was associated with the comorbidity chronic gastrointestinal diseases as well as osteoarthritis and rheumatoid arthritis. To ensure that iatrogenic risks remain minimal for older adults with diabetes, the clinical comorbidities should be considered.

Indexed as

Arthritis, RheumatoidDiabetes MellitusGastrointestinal DiseasesOsteoarthritisAgedAnti-Inflammatory AgentsBenzodiazepinesChronic DiseaseComorbidityCross-Sectional StudiesDiureticsHumansInappropriate PrescribingOutpatientsPotentially Inappropriate Medication ListPrevalenceAnti-Inflammatory AgentsBenzodiazepinesDiureticscomorbiditydiabeteselderpolypharmacypotentially inappropriate medication (PIM)prevalence

Identifiers

PMID36203703
PMCPMC9530933
OpenAlexW4296396570

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.